BRIEF published on 01/28/2026 at 18:53, 2 months 29 days ago ABIONYX: Publication of the Number of Voting Rights and Shares Euronext Paris Share Capital Voting Rights Financial Transparency ABIONYX
BRIEF published on 01/23/2026 at 19:05, 3 months 3 days ago ABIONYX Pharma unveils its 2026 financial calendar Critical Care Innovative Therapies ABIONYX Pharma Sepsis Financial Calendar 2026
BRIEF published on 01/23/2026 at 19:05, 3 months 3 days ago ABIONYX Pharma Announces 2026 Financial Calendar Financial Calendar Biopharma ABIONYX Pharma 2026 Updates Sepsis Care
PRESS RELEASE published on 01/23/2026 at 19:00, 3 months 3 days ago Inside Information / Other news releases ABIONYX Pharma announces its financial calendar for 2026, including key events and dates for cash position updates and results releases Financial Calendar ABIONYX Pharma Sepsis 2026 Therapeutic Era
BRIEF published on 01/07/2026 at 19:17, 3 months 19 days ago ABIONYX Pharma's Half-Yearly Review of Liquidity Contract Liquidity Contract TP ICAP Europe Stock Market Transactions ABIONYX Pharma Stocks And Cash
PRESS RELEASE published on 01/07/2026 at 19:12, 3 months 19 days ago Inside Information / Other news releases ABIONYX Pharma releases half-yearly report on liquidity contract with TP ICAP (Europe) SA, detailing shares and cash balance for 2025 Liquidity Contract Shares TP ICAP Cash Balance ABIONYX Pharma
BRIEF published on 12/16/2025 at 21:23, 4 months 10 days ago ABIONYX Pharma Announces a Capital Increase Fundraising Capital Increase Biopharmaceutical ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 4 months 10 days ago ABIONYX Pharma Announces €1.8 Million Capital Increase Capital Increase Subscription Rights Euronext Listing ABIONYX Pharma Financial Visibility
PRESS RELEASE published on 12/16/2025 at 21:18, 4 months 10 days ago Inside Information / Other news releases ABIONYX Pharma launches €1.8m capital increase with removal of preferential subscription rights, subscription price at 3.10 euros for new shares, extending financial visibility until 2026 Capital Increase Biopharma Preferential Subscription Rights ABIONYX Pharma Financial Visibility
BRIEF published on 12/05/2025 at 18:05, 4 months 21 days ago ABIONYX Reports Monthly Voting Rights and Share Data Euronext Paris Share Capital Voting Rights AMF Regulations ABIONYX Pharma
Published on 04/25/2026 at 03:10, 2 days 6 hours ago BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 2 days 11 hours ago Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:00, 2 days 11 hours ago Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 2 days 18 hours ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 15:00, 2 days 18 hours ago First Canadian Graphite Appoints Scott Kelly As Chief Financial Officer
Published on 04/27/2026 at 09:05, 41 minutes ago OneLayer Launches Sentry Partner Program to Extend Zero Trust Security for Private Cellular Networks
Published on 04/27/2026 at 09:00, 45 minutes ago Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY
Published on 04/27/2026 at 09:00, 45 minutes ago Original-Research: GFT Technologies SE (von NuWays AG): BUY
Published on 04/27/2026 at 09:00, 45 minutes ago Original-Research: ATOSS Software SE (von NuWays AG): BUY
Published on 04/24/2026 at 17:45, 2 days 16 hours ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
Published on 04/24/2026 at 16:37, 2 days 17 hours ago Availability of the 2025 Universal Registration Document (URD)
Published on 04/23/2026 at 19:27, 3 days 14 hours ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 3 days 15 hours ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
